Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders

International Journal of Neuropsychopharmacology

Volumn 1, Issue 2, 1998, Pages 125-129

  Serretti, Alessandro ^a   Lilli, Roberta ^a   Lorenzi, Cristina ^a,b   Franchini, Linda ^a   Smeraldi, Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Bipolar disorder; Dopamine receptor d3; Follow up studies; Lithium; Treatment outcome

Indexed keywords

EID: 0000197187     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145798001230     Document Type: Article

References (34)

1. Carli M, Morissette M, Hebert C, Di Paolo T, Reader TA (1997). Effects of a chronic lithium treatment on central dopamine neurotransporters. Biochemical Pharmacology 54, 391-397.
2. Cohen J (1988). Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates.
3. De Bruyn A, Souery D, Mendelbaum K, Mendlewicz J, Van Broeckhoven C (1996). A linkage study between bipolar disorder and genes involved in dopaminergic and GABAergic neurotransmission. Psychiatric Genetics 6, 67-73.
4. Dunner DL, Fleiss JL, Fieve RR (1976). Lithium carbonate prophylaxis failure. British Journal of Psychiatry 129, 40-44.
5. Dziedzicka-Wasylewska M, Mackowiak M, Fijat K, Wedzony K (1996). Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. Journal of Neural Transmission - General Section 103, 765-776.
6. Endicott J, Spitzer R (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 35, 837-844.
7. Franchini L, Gasperini M, Smeraldi E (1994). A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine. Journal of Affective Disorders 32, 225-231.
8. Gasperini M, Scherillo P, Manfredonia M, Franchini L, Smeraldi E (1993). A study of relapses in subjects with mood disorder on lithium treatment. European Neuropsychopharmacology 3, 103-110.
9. Gelenberg AJ, Carroll JA, Baudhuin MG, Jefferson JW, Greist JH (1989). The meaning of serum lithium levels in maintenance therapy of mood disorders: a review of the literature. Journal of Clinical Psychiatry 50, 17-22.
10. Goodwin F, Jamison K (1990). Manic-depressive illness. New York: Oxford University Press.
11. Grof P, Alda M, Grof E, Zvolsky P, Walsh M (1994). Lithium response and genetics of affective disorders. Journal of Affective Disorders 32, 85-95.
12. Hamilton M (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278-296.
13. Jonsson E, Sedvall G, Brene S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA (1996). Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry 40, 1032-1043.
14. Joyce JN, Goldsmith SG, Gurevich EV (1997). Limbic circuits and monoamine receptors - dissecting the effects of antipsychotics from disease processes. Journal of Psychiatric Research 31, 197-217.
15. Krebs MO, Sautel F, Bourdel MC, Sokoloff P, Schwartz JC, Olie JP, Loo H, Poirier MF (1998). Dopamine D-3 receptor gene variants and substance abuse in schizophrenia. Molecular Psychiatry 3, 337-341.
16. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jonsson E, Sedvall G, Schwartz JC (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatric Genetics 2, 249-256.
17. Lipp O, Mahieu B, Souery D, Serretti A, Cavallini C, Verga M, Van Broeckhoven C, Macciardi F, Mendlewicz J (1997). Molecular genetics of bipolar disorders: implication for psychotropic drugs. Xth Congress of the European College of Neuropsychopharmacology, Vienna, Austria.
18. Maj M, Pirozzi R, Magliano L, Bartoli L (1998). Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. American Journal of Psychiatry 155, 30-35.
19. Maj M, Pirozzi R, Starace F (1989). Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. Journal of Affective Disorders 17, 237-241.
20. Malhotra AK, Goldman D, Buchanan RW, Rooney W, Clifton A, Kosmidis MH, Breier A, Pickar D (1998). The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Molecular Psychiatry 3, 72-75.
21. McGuffin P, Farmer A, Harvey I (1991). A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry 48, 764-770.
22. Mendlewicz J, Fieve RR, Stallone F, Fleiss JL (1972). Genetic history as a predictor of lithium response in manic-depressive illness. Lancet 1, 599-600.
23. Mendlewicz J, Verbanck P, Linkowski P, Wilmotte J (1978). Lithium accumulation in erythrocytes of manic-depressive patients: an in vivo twin study. British Journal of Psychiatry 133, 436-444.
24. Oruc L, Furac I, Croux C, Jakovljevic M, Kracun I, Folnegovic V, Van Broeckhoven C (1996). Association study between bipolar disorder and candidate genes involved in dopamine-serotonin metabolism and GABAergic neurotransmission: a preliminary report. Psychiatric Genetics 6, 213-217.
25. Parsian A, Chakraverty S, Todd RD (1995). Possible association between the dopamine D3 receptor gene and bipolar affective disorder. American Journal of Medical Genetics 60, 234-237.
26. Schwartz JC, Levesque D, Martres MP, Sokoloff P (1993). Dopamine D3 receptor: basic and clinical aspects. Clinical Neuropharmacology 16, 295-314.
27. Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin RW (1996). Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics 97, 714-719.
28. Solomon DA, Keller MB, Leon AC, Mueller TI, Shea MT, Warshaw M, Maser JD, Coryell W, Endicott J (1997). Recovery from major depression - a 10-year prospective follow-up across multiple episodes. Archives of General Psychiatry 54, 1001-1006.
29. Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, Van Broeckhoven C, Mendlewicz J (1996). Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. American Journal of Medical Genetics 67, 551-555.
30. Souery D, Lipp O, Mahieu B, Serretti A, Cavallini C, Macciardi F, Van Broeckhoven C, Mendlewicz J (In Press). European Collaborative Project on Affective Disorders: Interactions between genetic and psychosocial vulnerability factors. Psychiatric Genetics.
31. Staner L, Hilger C, Hentges F, Monreal J, Hoffmann A, Couturier M, Lebon O, Stefos G, Souery D, Mendlewicz J (1998). Association between novelty-seeking and the dopamine D3 receptor gene in bipolar patients - a preliminary report. American Journal of Medical Genetics 81, 192-194.
32. Turecki G, Alda M, Grof P, Martin R, Cavazzoni PA, Duffy A, Maciel P, Rouleau GA (1996). No association between chromosome-18 markers and lithium-responsive affective disorders. Psychiatry Research 63, 17-23.
33. Willner P (1995). Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DJ (Eds.), Psychopharmacology: The Fourth Generation of Progress (pp. 921-931). New York: Raven Press.
34. Young R, Biggs J, Ziegler V, Meyer D (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435.